Geneos Wealth Management Inc. Purchases 6,250 Shares of Celsius Holdings Inc. $CELH

Key Points

• Geneos Wealth Management Inc. increased its stake in Celsius Holdings Inc. by 30.4% in the first quarter, bringing its total holdings to 26,804 shares valued at approximately $955,000.
• Analysts have raised their price targets for Celsius Holdings, with firm estimates ranging from $54.00 to $73.00, suggesting strong market confidence in the company's growth potential.
• Insider transactions indicate a mixed sentiment, as major shareholder William H. Milmoe sold 300,000 shares, while the overall insider ownership remains at 2.55% of the company's stock.

Geneos Wealth Management Inc. increased its position in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 30.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,804 shares of the company's stock after purchasing an additional 6,250 shares during the quarter. Geneos Wealth Management Inc.'s holdings in Celsius were worth $955,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Triumph Capital Management lifted its position in Celsius by 41.5% during the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock worth $1,065,000 after purchasing an additional 11,863 shares during the period. Fifth Third Bancorp lifted its position in Celsius by 62.9% during the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares during the period. GAMMA Investing LLC lifted its position in Celsius by 4,164.4% during the first quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock worth $2,604,000 after purchasing an additional 71,378 shares during the period. Oppenheimer & Co. Inc. lifted its position in Celsius by 14.0% during the first quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock worth $348,000 after purchasing an additional 1,199 shares during the period. Finally, Cambridge Investment Research Advisors Inc. raised its stake in Celsius by 21.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock worth $1,621,000 after acquiring an additional 8,009 shares in the last quarter. Institutional investors own 60.95% of the company's stock.

Insider Activity

In other Celsius news, CFO Jarrod Langhans sold 5,000 shares of the stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the transaction, the chief financial officer directly owned 104,227 shares in the company, valued at approximately $6,253,620. This represents a 4.58% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder William H. Milmoe sold 300,000 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total value of $14,181,000.00. Following the transaction, the insider owned 18,017,770 shares in the company, valued at $851,699,987.90. The trade was a 1.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 991,470 shares of company stock worth $47,307,297. Company insiders own 2.20% of the company's stock.

Celsius Trading Down 3.0%

CELH stock traded down $1.75 during trading on Monday, hitting $56.07. The company had a trading volume of 4,789,024 shares, compared to its average volume of 5,547,694. The business has a 50-day moving average of $52.57 and a 200-day moving average of $42.43. Celsius Holdings Inc. has a one year low of $21.10 and a one year high of $63.50. The stock has a market cap of $14.46 billion, a PE ratio of 151.54, a PEG ratio of 1.31 and a beta of 1.33. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. The firm had revenue of $739.30 million for the quarter, compared to analysts' expectations of $632.13 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The company's revenue for the quarter was up 83.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.28 EPS. Research analysts predict that Celsius Holdings Inc. will post 0.89 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CELH has been the subject of several research analyst reports. The Goldman Sachs Group initiated coverage on Celsius in a research note on Thursday. They set a "buy" rating and a $72.00 target price for the company. Wells Fargo & Company boosted their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research note on Wednesday, June 4th. Wall Street Zen downgraded Celsius from a "buy" rating to a "hold" rating in a research note on Sunday, August 17th. Maxim Group boosted their target price on Celsius from $50.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, Bank of America boosted their target price on Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research note on Friday, August 8th. Eighteen research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $61.95.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.